C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -104,994 | -105,316 | -132,493 | -128,175 | -83,892 |
| Depreciation Amortization | -783 | -3,578 | -1,499 | 3,103 | 4,090 |
| Accounts receivable | 701 | 8,697 | -10,327 | 4,244 | -1,232 |
| Accounts payable and accrued liabilities | -468 | -119 | 273 | -3,333 | -1,179 |
| Other Working Capital | -29,282 | 7,648 | -6,938 | -16,779 | -30,090 |
| Other Operating Activity | 36,132 | 27,511 | 44,146 | 35,001 | 25,338 |
| Operating Cash Flow | $-98,694 | $-65,157 | $-106,838 | $-105,939 | $-86,965 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -227,074 | -284,321 | 160,057 | -219,527 | -188,059 |
| PPE Investments | -607 | -180 | -1,708 | -5,496 | -1,277 |
| Sale Of Investment | 219,080 | 233,231 | N/A | 283,445 | N/A |
| Investing Cash Flow | $-8,601 | $-51,270 | $158,349 | $58,422 | $-189,336 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -12,500 | N/A | N/A |
| Common Stock Issued | 126,318 | 45,148 | 57,731 | 777 | 171,795 |
| Common Stock Repurchased | -193 | -194 | -110 | 0 | N/A |
| Other Financing Activity | 274 | 382 | 368 | 370 | -395 |
| Financing Cash Flow | $126,399 | $45,336 | $45,489 | $1,147 | $171,400 |
| Beginning Cash Position | 58,942 | 130,033 | 33,033 | 79,403 | 184,304 |
| End Cash Position | 78,046 | 58,942 | 130,033 | 33,033 | 79,403 |
| Net Cash Flow | $19,104 | $-71,091 | $97,000 | $-46,370 | $-104,901 |
| Free Cash Flow | |||||
| Operating Cash Flow | -98,694 | -65,157 | -106,838 | -105,939 | -86,965 |
| Capital Expenditure | -607 | -180 | -1,708 | -5,496 | -1,277 |
| Free Cash Flow | -99,301 | -65,337 | -108,546 | -111,435 | -88,242 |